Adverse effects associated with the use of anabolic agents in athletes: systematic review
DOI:
https://doi.org/10.30827/ars.v59i1.7278Keywords:
Anabolic Agents, Adverse Effects, Sports, Systematic ReviewAbstract
Objective: Review the scientific documentation on the adverse effects of anabolic agents in adults who practice sports.
Method: Descriptive cross-sectional study and critical analysis of the works recovered through systematic review. The data were obtained from direct consultation and access, via the Internet, to the following bibliographic databases in the field of health sciences: MEDLINE (vía PubMed), The Cochrane Library, Scopus, Cumulative Index to Nursing and Allied Health Literature (CINHAL), Web of Science y PsycINFO until October 2017. The use of Descriptors was considered appropriate «Sports», «Anabolic Agents/Adverse effects», using the filters: «Clinical Trial», «Comparative Study», «Humans» y «Adult:19+years».
Results: Of the 108 recovered references, after applying the inclusion and exclusion criteria, 15 articles were selected for review. One job was found in the bibliographic listings. By evaluating the quality of selected articles for review using the CONSORT questionnaire, scores ranged from 11,5 to 15,5 on a maximum score of 25.
Conclusions: The revised work presented a higher obsolescence than expected in the area of health sciences. The articles were written preferably in English. It was observed, that the AAS had adverse effects, especially at the cardiovascular, behavioral level and appearance of side effects associated with the consumption of anabolic agents. Although there are discrepancies between the magnitude of them at the cardiovascular level and their potential damage.
Downloads
References
Hoffman JR, Ratamess NA. Medical issues associated with anabolic steroid use: are they exaggerated? J Sports Sci Med. 2006;5(2):182-93.
Iriart JAB, Andrade TM de. Body-building, steroid use, and risk perception among young body-builders from a low-income neighborhood in the city of Salvador, Bahia State, Brazil. Cad Saude Publica. 2002;18(5):1379-87. DOI: 10.1590/S0102-311X2002000500031
Baggish AL, Weiner RB, Kanayama G, Hudson JI, Picard MH, Hutter AM, et al.. Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail. 2010;3(4):472-6. DOI: 10.1161/CIRCHEARTFAILURE.109.931063
Piacentino D, Kotzalidis GD, Del Casale A, Aromatario MR, Pomara C, Girardi P, et al.. Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review. Curr Neuropharmacol. 2015;13(1):101-21. DOI: 10.2174/1570159X13666141210222725
Börjesson A, Gårevik N, Dahl M-L, Rane A, Ekström L. Recruitment to doping and help-seeking behavior of eight female AAS users. Subst Abuse Treat Prev Policy. 2016;11:11. DOI: 10.1186/s13011-016-0056-3
Pagonis TA, Angelopoulos NV, Koukoulis GN, Hadjichristodoulou CS, Toli PN. Psychiatric and hostility factors related to use of anabolic steroids in monozygotic twins. Eur Psychiatry. 2006;21(8):563-9. DOI: 10.1016/j.eurpsy.2005.11.002
Horn S, Gregory P, Guskiewicz KM. Self-reported anabolic-androgenic steroids use and musculoskeletal injuries: findings from the center for the study of retired athletes health survey of retired NFL players. Am J Phys Med Rehabil. 2009;88(3):192-200. DOI: 10.1097/PHM.0b013e318198b622
Socas L, Zumbado M, Pérez-Luzardo O, Ramos A, Pérez C, Hernández JR, et al.. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med. 2005;39(5):e27. DOI: 10.1136/bjsm.2004.013599
Dawson RT. Drugs in sport - the role of the physician. J Endocrinol. 2001;170(1):55-61. DOI: 10.1677/joe.0.1700055
Kersey RD, Elliot DL, Goldberg L, Kanayama G, Leone JE, Pavlovich M, et al.. National Athletic Trainers’ Association position statement: anabolic-androgenic steroids. J Athl Train. 47(5):567-88. DOI: 10.4085/1062-6050-47.5.08
Cobos-Carbo A, Augustovski F. Declaración CONSORT 2010: actualización de la lista de comprobación para informar ensayos clínicos aleatorizados de grupos paralelos. Med Clin (Barc). 2011;137(5):213-5. DOI: 10.1016/j.medcli.2010.09.034
Souza L da CM, da Cruz LA, Cerqueira E de MM, Meireles J. Micronucleus as biomarkers of cancer risk in anabolic androgenic steroids users. Hum Exp Toxicol. 2017;36(3):302-10. DOI: 10.1177/0960327116650005
Ilić I, Djordjević V, Stanković I, Vlahović-Stipac A, Putniković B, Babić R, et al.. The impact of anabolic androgenic steroids abuse and type of training on left ventricular remodeling and function in competitive athletes. Vojnosanit Pregl. 2014;71(4):383-9.
Kasikcioglu E, Oflaz H, Umman B, Bugra Z. Androgenic anabolic steroids also impair right ventricular function. Int J Cardiol. 2009;134(1):123-5. DOI: 10.1016/j.ijcard.2007.12.027
D’Andrea A, Caso P, Salerno G, Scarafile R, De Corato G, Mita C, et al.. Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: a Doppler myocardial and strain imaging analysis. Br J Sports Med. 2007;41(3):149-55. DOI: 10.1136/bjsm.2006.030171
Graham MR, Grace FM, Boobier W, Hullin D, Kicman A, Cowan D, et al.. Homocysteine induced cardiovascular events: a consequence of long term anabolic-androgenic steroid (AAS) abuse. Br J Sports Med. 2006;40(7):644-8. DOI: 10.1136/bjsm.2005.025668
Climstein M, O’Shea P, Adams KJ, DeBeliso M. The effects of anabolic-androgenic steroids upon resting and peak exercise left ventricular heart wall motion kinetics in male strength and power athletes. J Sci Med Sport. 2003;6(4):387-97. DOI: 10.1016/S1440-2440(03)80265-7
Grace F, Sculthorpe N, Baker J, Davies B. Blood pressure and rate pressure product response in males using high-dose anabolic androgenic steroids (AAS). J Sci Med Sport. 2003;6(3):307-12. DOI: 10.1016/S1440-2440(03)80024-5
Iñigo MA, Arrimadas E, Arroyo D. 43 cycles of anabolic steroid treatment studied in athletes: the uses and secondary effects. Rev Clin Esp. 2000;200(3):133-8.
Hislop MS, Ratanjee BD, Soule SG, Marais AD. Effects of anabolic-androgenic steroid use or gonadal testosterone suppression on serum leptin concentration in men. Eur J Endocrinol. 1999;141(1):40-6. DOI: 10.1530/eje.0.1410040
Giorgi A, Weatherby RP, Murphy PW. Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study. J Sci Med Sport. 1999;2(4):341-55. DOI: 10.1016/S1440-2440(99)80007-3
Palatini P, Giada F, Garavelli G, Sinisi F, Mario L, Michieletto M, et al.. Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol. 1996;36(12):1132-40. DOI: 10.1002/j.1552-4604.1996.tb04167.x
Porcerelli JH, Sandler BA. Narcissism and empathy in steroid users. Am J Psychiatry. 1995;152(11):1672-4. DOI: 10.1176/ajp.152.11.1672
Pope HG, Kouri EM, Hudson JI. Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry. 2000;57(2):133-40; discussion 155-6. DOI:10.1001/archpsyc.57.2.133
Graham MR, Baker JS, Evans P, Kicman A, Cowan D, Hullin D, et al.. Physical effects of short-term recombinant human growth hormone administration in abstinent steroid dependency. Horm Res. 2008;69(6):343-54. DOI: 10.1159/000117390
Babigian A, Silverman RT. Management of gynecomastia due to use of anabolic steroids in bodybuilders. Plast Reconstr Surg. 2001;107(1):240-2.
Melnik B, Jansen T, Grabbe S. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem. J Dtsch Dermatol Ges. 2007;5(2):110-7. DOI: 10.1111/j.1610-0387.2007.06176.x
O’Sullivan AJ, Kennedy MC, Casey JH, Day RO, Corrigan B, Wodak AD. Anabolic-androgenic steroids: medical assessment of present, past and potential users. Med J Aust. 2000;173(6):323-7.
Franco-López A, Sanz-Valero J, Culebras JM. Publicar en castellano, o en cualquier otro idioma que no sea inglés, negativo para el factor de impacto y citaciones. J Negat No Posit Results. 2016;(2):65–70. DOI: 10.19230/jonnpr.2016.1.2.1005
Sanz-Valero J, Wanden-Berghe C. Análisis bibliométrico de la producción científica, indizada en MEDLINE, sobre los servicios de salud proporcionados por las unidades de hospitalización a domicilio. Hosp Domic. 1(1);2017:21-34. DOI: 10.22585/hospdomic.v1i1.3
Ip EJ, Barnett MJ, Tenerowicz MJ, Kim JA, Wei H, Perry PJ. Women and anabolic steroids: an analysis of a dozen users. Clin J Sport Med. 2010;20(6):475-81. DOI: 10.1097/JSM.0b013e3181fb5370
Sahraian MA, Mottamedi M, Azimi AR, Moghimi B. Androgen-induced cerebral venous sinus thrombosis in a young body builder: case report. BMC Neurol. 2004;4(1):22. DOI: 10.1186/1471-2377-4-22
Su TP, Pagliaro M, Schmidt PJ, Pickar D, Wolkowitz O, Rubinow DR. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA. 1993;269(21):2760-4. DOI:10.1001/jama.1993.03500210060032
Derman RJ. Effects of sex steroids on women’s health: implications for practitioners. Am J Med. 1995;98(1A):137S-43S. DOI: 10.1016/S0002-9343(99)80072-2
Pavlatos AM, Fultz O, Monberg MJ, Vootkur A, Pharmd. Review of oxymetholone: a 17alpha-alkylated anabolic-androgenic steroid. Clin Ther. 2001;23(6):789-801; discussion 771. DOI: 10.1016/S0149-2918(01)80070-9
Lee P, Zhu C-C, Sadick NS, Diwan AH, Zhang PS, Liu JS, et al.. Expression of androgen receptor coactivator ARA70/ELE1 in androgenic alopecia. J Cutan Pathol. 2005;32(8):567-71. DOI: 10.1111/j.0303-6987.2005.00397.x
Domingo-Pueyo A, Sanz-Valero J, Wanden-Berghe C. Effects of occupational exposure to chromium and its compounds: a systematic review. Arch Prev Riesgos Laborales. 2014;17(3):142-53. DOI: 10.12961/aprl.2014.17.3.03
Bruno M. Anabolic steroids and their abuse in sports. Clin Ter. 1990;135(3):159-72.
Alén M, Rahkila P. Reduced high-density lipoprotein-cholesterol in power athletes: use of male sex hormone derivates, an atherogenic factor. Int J Sports Med. 1984;5(6):341-2. DOI: 10.1055/s-2008-1025929
Brennan BP, Kanayama G, Hudson JI, Pope HG. Human growth hormone abuse in male weightlifters. Am J Addict. 2011;20(1):9-13. DOI: 10.1111/j.1521-0391.2010.00093.x
Fanton L, Belhani D, Vaillant F, Tabib A, Gomez L, Descotes J, et al.. Heart lesions associated with anabolic steroid abuse: comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbits. Exp Toxicol Pathol. 2009;61(4):317-23. DOI: 10.1016/j.etp.2008.09.007
Bond AJ, Choi PY, Pope HG. Assessment of attentional bias and mood in users and non-users of anabolic-androgenic steroids. Drug Alcohol Depend. 1995;37(3):241-5. DOI: 10.1016/0376-8716(94)01071-R
Downloads
Published
How to Cite
Issue
Section
License
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
